Disclosure 13 Page

CHN

KOR

Disclosure 목록
No	Title	Date	Date
192	매출액또는손익구조30%(대규모법인은15%)이상변동	엘앤씨바이오	2022.02.17
191	타법인주식및출자증권취득결정(자율공시)	엘앤씨바이오	2022.02.16
190	주식등의대량보유상황보고서(일반)	이환철	2022.02.04
189	주식등의대량보유상황보고서(일반)	이환철	2022.01.24
188	임원ㆍ주요주주특정증권등소유상황보고서	이광인	2021.12.30
187	주식등의대량보유상황보고서(일반)	이환철	2021.12.30
186	현금ㆍ현물배당결정	엘앤씨바이오	2021.12.15
185	주주명부폐쇄기간또는기준일설정	엘앤씨바이오	2021.12.14
184	주식등의대량보유상황보고서(일반)	이환철	2021.12.08
183	분기보고서 (2021.09)	엘앤씨바이오	2021.11.11
182	주식등의대량보유상황보고서(일반)	이환철	2021.11.05
181	주식등의대량보유상황보고서(일반)	이환철	2021.10.29
180	주식등의대량보유상황보고서(일반)	이환철	2021.10.22
179	주식등의대량보유상황보고서(일반)	이환철	2021.10.06
178	기업설명회(IR)개최	엘앤씨바이오	2021.09.29

검색

L&C Bio Co., Ltd. Business Registration No. (129-86-64008) Privacy Policy Seoul Office / R&D Center 82, Naruteo-ro, Seocho-gu, Seoul (Jamwon-dong) Seoul Office / Sales & Marketing Center Room 201, 105, HyoRyeong-ro (Beomchang Bldg., Bangbae-dong), Seocho-gu, Seoul Headquarters / Human Tissue Plant Units 605–607, 474, Dunchon-daero, Suntech City (Sangdaewon-dong), Jungwon-gu, Seongnam-si, Gyeonggi-do Pharmaceutical Plant Building A, 1F, 104, Gongdan 2-ro, (Sinsohyeon-dong), Anseong-si, Gyeonggi-do L&C ES Headquarters 2F #203–204, 90, Centum-dong-ro, L&C ES (Jaesong-dong, Centum Phil Bldg. 2), Haeundae-gu, Busan L&C ES R&D Center 4F, 76, Naruteo-ro (ImageUp Bldg.), Seocho-gu, Seoul L&C Medicare Headquarters Room 202, 105, HyoRyeong-ro (Beomchang Bldg., Bangbae-dong), Seocho-gu, Seoul L&C China Headquarters No. 97, Building 32-1, Jixiangnan Yuan, Luojia Town, Kunshan, Jiangsu, China

Cutomer Service

+82-2-541-8577